Trials / Withdrawn
WithdrawnNCT01669668
Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)
Radiofrequency Ablation Under Ideal Conditions in Hepatocellular Carcinoma
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial studies how effectively radiofrequency ablation prevents recurrence of hepatocellular carcinoma (HCC) in patients with easily removable tumors. Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | radiofrequency ablation | Undergo RFA |
| PROCEDURE | laparoscopy | Undergo laparoscopic ultrasound |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2012-08-21
- Last updated
- 2014-07-16
Source: ClinicalTrials.gov record NCT01669668. Inclusion in this directory is not an endorsement.